PortalPublikationenCirculating miRNAs as surrogate markers for circulating tumo...

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.

Standard

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. / Madhavan, Dharanija; Zucknick, Manuela; Wallwiener, Markus; Cuk, Katarina; Modugno, Caroline; Scharpff, Martina; Schott, Sarah; Heil, Jörg; Turchinovich, Andrey; Yang, Rongxi; Benner, Axel; Riethdorf, Sabine; Trumpp, Andreas; Sohn, Christof; Pantel, Klaus; Schneeweiss, Andreas; Burwinkel, Barbara.

in: CLIN CANCER RES, Jahrgang 18, Nr. 21, 21, 2012, S. 5972-5982.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Madhavan, D, Zucknick, M, Wallwiener, M, Cuk, K, Modugno, C, Scharpff, M, Schott, S, Heil, J, Turchinovich, A, Yang, R, Benner, A, Riethdorf, S, Trumpp, A, Sohn, C, Pantel, K, Schneeweiss, A & Burwinkel, B 2012, 'Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.', CLIN CANCER RES, Jg. 18, Nr. 21, 21, S. 5972-5982. <http://www.ncbi.nlm.nih.gov/pubmed/22952344?dopt=Citation>

APA

Madhavan, D., Zucknick, M., Wallwiener, M., Cuk, K., Modugno, C., Scharpff, M., Schott, S., Heil, J., Turchinovich, A., Yang, R., Benner, A., Riethdorf, S., Trumpp, A., Sohn, C., Pantel, K., Schneeweiss, A., & Burwinkel, B. (2012). Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. CLIN CANCER RES, 18(21), 5972-5982. [21]. http://www.ncbi.nlm.nih.gov/pubmed/22952344?dopt=Citation

Vancouver

Madhavan D, Zucknick M, Wallwiener M, Cuk K, Modugno C, Scharpff M et al. Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. CLIN CANCER RES. 2012;18(21):5972-5982. 21.

Bibtex

@article{c583929e400a4f6889fb58e1f9685d5a,
title = "Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.",
abstract = "The use of circulating tumor cells (CTC) as a prognostic marker in metastatic breast cancer (MBC) has been well established. However, their efficacy and accuracy are still under scrutiny mainly because of methods of their enrichment and identification. We hypothesized that circulating miRNAs can predict the CTC status of patients with MBC, and tested for the same. Furthermore, we aimed at establishing a panel of circulating miRNAs capable of differentiating MBC cases from healthy controls.",
keywords = "Humans, Female, Reproducibility of Results, Prognosis, Cell Count, Transcriptome, MicroRNAs/*blood/genetics, Neoplastic Cells, Circulating/*metabolism, Breast Neoplasms/*blood/genetics/mortality/*pathology, *Tumor Markers, Biological/blood/genetics, Humans, Female, Reproducibility of Results, Prognosis, Cell Count, Transcriptome, MicroRNAs/*blood/genetics, Neoplastic Cells, Circulating/*metabolism, Breast Neoplasms/*blood/genetics/mortality/*pathology, *Tumor Markers, Biological/blood/genetics",
author = "Dharanija Madhavan and Manuela Zucknick and Markus Wallwiener and Katarina Cuk and Caroline Modugno and Martina Scharpff and Sarah Schott and J{\"o}rg Heil and Andrey Turchinovich and Rongxi Yang and Axel Benner and Sabine Riethdorf and Andreas Trumpp and Christof Sohn and Klaus Pantel and Andreas Schneeweiss and Barbara Burwinkel",
year = "2012",
language = "English",
volume = "18",
pages = "5972--5982",
journal = "CLIN CANCER RES",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "21",

}

RIS

TY - JOUR

T1 - Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.

AU - Madhavan, Dharanija

AU - Zucknick, Manuela

AU - Wallwiener, Markus

AU - Cuk, Katarina

AU - Modugno, Caroline

AU - Scharpff, Martina

AU - Schott, Sarah

AU - Heil, Jörg

AU - Turchinovich, Andrey

AU - Yang, Rongxi

AU - Benner, Axel

AU - Riethdorf, Sabine

AU - Trumpp, Andreas

AU - Sohn, Christof

AU - Pantel, Klaus

AU - Schneeweiss, Andreas

AU - Burwinkel, Barbara

PY - 2012

Y1 - 2012

N2 - The use of circulating tumor cells (CTC) as a prognostic marker in metastatic breast cancer (MBC) has been well established. However, their efficacy and accuracy are still under scrutiny mainly because of methods of their enrichment and identification. We hypothesized that circulating miRNAs can predict the CTC status of patients with MBC, and tested for the same. Furthermore, we aimed at establishing a panel of circulating miRNAs capable of differentiating MBC cases from healthy controls.

AB - The use of circulating tumor cells (CTC) as a prognostic marker in metastatic breast cancer (MBC) has been well established. However, their efficacy and accuracy are still under scrutiny mainly because of methods of their enrichment and identification. We hypothesized that circulating miRNAs can predict the CTC status of patients with MBC, and tested for the same. Furthermore, we aimed at establishing a panel of circulating miRNAs capable of differentiating MBC cases from healthy controls.

KW - Humans

KW - Female

KW - Reproducibility of Results

KW - Prognosis

KW - Cell Count

KW - Transcriptome

KW - MicroRNAs/blood/genetics

KW - Neoplastic Cells, Circulating/metabolism

KW - Breast Neoplasms/blood/genetics/mortality/pathology

KW - Tumor Markers, Biological/blood/genetics

KW - Humans

KW - Female

KW - Reproducibility of Results

KW - Prognosis

KW - Cell Count

KW - Transcriptome

KW - MicroRNAs/blood/genetics

KW - Neoplastic Cells, Circulating/metabolism

KW - Breast Neoplasms/blood/genetics/mortality/pathology

KW - Tumor Markers, Biological/blood/genetics

M3 - SCORING: Journal article

VL - 18

SP - 5972

EP - 5982

JO - CLIN CANCER RES

JF - CLIN CANCER RES

SN - 1078-0432

IS - 21

M1 - 21

ER -